Evidence map›Paper›PMID 24515950›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2014

Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy.

Yu Cheng, Tennyson L Doane, Chi-Hung Chuang, Assem Ziady, Clemens Burda

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Functional Polymer Nanocarriers for Photodynamic Therapy.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Nanotechnology for Cancer Therapy Based on Chemotherapy.Molecules (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu ChengDepartment of Chemistry, Case Western Reserve University, Cleveland, Ohio.
Tennyson L Doane
Chi-Hung Chuang
Assem Ziady
Clemens Burda

Funding

Dysregulation of Nrf2 in CF epitheliaR01HL109362 · NHLBI · EMORY UNIVERSITY · PI ZIADY, ASSEM G · 2011 to 2014
$1.5M
Dual-Receptor Targeted Nanoparticles for Photodynamic Therapy of Brain CancerR01EB012099 · NIBIB · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BROOME, ANN-MARIE · 2010 to 2013
$1.3M
NHLBI NIH HHS R01 HL109362NIBIB NIH HHS 5R01EB012099NIBIB NIH HHS R01 EB012099
6 · The paper itself

Abstract

A photoprecursor Pc 227 is covalently bound onto gold nanoparticles (Au NPs) to produce the known photodynamic therapy (PDT) drug Pc 4 upon 660 nm photoirradiation. The photochemical formation of the photoproduct Pc 4 is identified by spectroscopy, chromatography, and mass spectrometry and its PDT efficacy is equal to Pc 4 when administered non-covalently by Au NPs, with the added benefit of improved covalent delivery and targeted NIR-triggered release from the covalent Pc 227-Au NP conjugate, while during transport the attached Pc 227 is quenched by the Au NP and PDT inactivated.

Indexed as

Infrared RaysPhotochemotherapyDrug CarriersGoldHeLa CellsHumansIndolesIsoindolesMetal NanoparticlesPharmaceutical PreparationsSpectrometry, FluorescenceSpectrometry, Mass, Electrospray IonizationDrug CarriersGoldIndolesIsoindolesPharmaceutical Preparationsphthalocyaninecaged druggold nanoparticlephotodynamic therapyphototriggered release

Identifiers

PMID24515950
PMCPMC4013205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.